BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21165402)

  • 1. Study of nonrandom chromosome aberrations in bone marrow and blood cells of patients with non-Hodgkin's lymphomas.
    Ankina MA; Pavlov VV; Shakhtarina SV; Panfyorova TA; Zavitaeva TA; Danilenko AA
    Bull Exp Biol Med; 2010 Oct; 149(5):621-4. PubMed ID: 21165402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic study of bone marrow and blood cells in patients with non-Hodgkin lymphoma before and after antitumor therapy.
    Ankina MA; Zavitaeva TA; Panferova TA; Shakhtarina SV; Pavlov VV
    Bull Exp Biol Med; 2007 Feb; 143(2):236-9. PubMed ID: 17970210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of (7p13p14) in non-Hodgkin's lymphoma.
    Jonveaux P; Le Coniat M; Derré J; Vecchione D; Berger R
    Cancer Genet Cytogenet; 1990 Nov; 50(1):53-6. PubMed ID: 2253189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytogenetic studies in patients with non-Hodgkin's lymphoma (nHL)].
    Haus O; Kozłowska J; Zubkiewicz L; Jagielski J; Kotlarek-Haus S
    Pol Arch Med Wewn; 1991 Sep; 86(3):132-41. PubMed ID: 1808598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial cytogenetic studies showing persistence of original clone in Hodgkin's disease.
    Reeves BR; Nash R; Lawler SD; Fisher C; Treleaven JG; Wiltshaw E
    Cancer Genet Cytogenet; 1990 Nov; 50(1):1-8. PubMed ID: 2253176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term cytogenetic effects of antineoplastic treatment in relation to secondary leukemia.
    Genuardi M; Zollino M; Serra A; Leone G; Mancini R; Mango G; Neri G
    Cancer Genet Cytogenet; 1988 Jul; 33(2):201-11. PubMed ID: 3383168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clusters of chromosome 9 aberrations are associated with clinico-pathologic subsets of non-Hodgkin's lymphoma.
    Offit K; Parsa NZ; Jhanwar SC; Filippa D; Wachtel M; Chaganti RS
    Genes Chromosomes Cancer; 1993 May; 7(1):1-7. PubMed ID: 7688550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal deletions in non-Hodgkin's malignant lymphomas.
    Jonveaux P; Berger R
    Cancer Genet Cytogenet; 1990 Oct; 49(2):265-9. PubMed ID: 2208063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Centromeric instability of chromosome 1 resulting in multibranched chromosomes, telomeric fusions, and "jumping translocations" of 1q in a human immunodeficiency virus-related non-Hodgkin's lymphoma.
    Sawyer JR; Swanson CM; Koller MA; North PE; Ross SW
    Cancer; 1995 Oct; 76(7):1238-44. PubMed ID: 8630904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
    Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
    Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial deletion of chromosome 2 in non-Hodgkin lymphoma.
    Berger R; Le Coniat M; Derré J; Vecchione D
    Cancer Genet Cytogenet; 1991 May; 53(1):113-7. PubMed ID: 2036632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous occurrence of der(1;7)(q10;p10) and t(14;18)(q32;q21) in non-Hodgkin's lymphoma: der(1;7) will appear as a secondary change in lymphoid neoplasia.
    Hsiao HH; Sashida G; Ito Y; Tachino M; Beppu H; Ohyashiki K
    Leuk Lymphoma; 2005 Jun; 46(6):949-50. PubMed ID: 16019545
    [No Abstract]   [Full Text] [Related]  

  • 13. An analysis of chromosome findings in non-Hodgkin's lymphomas.
    Kaneko Y; Abe R; Sampi K; Sakurai M
    Cancer Genet Cytogenet; 1982 Feb; 5(2):107-21. PubMed ID: 7039815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermediate- to high-grade histology of lymphomas carrying t(14;18) is associated with additional nonrandom chromosome changes.
    Richardson ME; Chen QG; Filippa DA; Offit K; Hampton A; Koduru PR; Jhanwar SC; Lieberman PH; Clarkson BD; Chaganti RS
    Blood; 1987 Aug; 70(2):444-7. PubMed ID: 3607281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myelofibrosis in a patient with diffuse large cell non Hodgkin's lymphoma and renal cancer.
    Mohren M; Essbach U; Franke A; Klink A; Maas C; Markmann I; Pelz AF; Jentsch-Ullrich K
    Leuk Lymphoma; 2003 Sep; 44(9):1603-7. PubMed ID: 14565665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of 14q in non-Hodgkin's lymphoma.
    Kristoffersson U; Heim S; Johnsson A; Mandahl N; Olsson H; Akerman M; Mitelman F
    Eur J Haematol; 1990 Apr; 44(4):261-4. PubMed ID: 2344888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type.
    Ott G; Katzenberger T; Greiner A; Kalla J; Rosenwald A; Heinrich U; Ott MM; Müller-Hermelink HK
    Cancer Res; 1997 Sep; 57(18):3944-8. PubMed ID: 9307277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missing Y chromosomes in lymph nodes from patients with non-Hodgkin's lymphoma.
    Bateman BJ; Sanger WG; Armitage JO
    Cancer Genet Cytogenet; 1987 Apr; 25(2):219-25. PubMed ID: 3828969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities involving chromosome 6 in newly diagnosed patients with non-Hodgkin's lymphoma. Nebraska Lymphoma Study Group.
    Schouten HC; Sanger WG; Weisenburger DD; Armitage JO
    Cancer Genet Cytogenet; 1990 Jul; 47(1):73-82. PubMed ID: 2357689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of bone marrow involvement in malignant lymphoma using fluorescence in situ hybridization: possible utility in the detection of micrometastasis.
    Huh HJ; Min HC; Cho HI; Chae SL; Lee DS
    Cancer Genet Cytogenet; 2008 Oct; 186(1):1-5. PubMed ID: 18786435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.